No Data
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
CareDx, JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Cantor Fitzgerald Maintains Organogenesis(ORGO.US) With Buy Rating, Maintains Target Price $3.5
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
Express News | Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of Nushield for Diabetic Foot Ulcers
Amniotic Membrane Market Research Report 2024-2032 Featuring Stryke, Smith & Nephew, Integra LifeSciences, MiMedx, Organogenesis Net, Wright Medical, Applied Biologics, FzioMed, Katena, Tissue-Tech